Associations of serum bile acids and amino acids with low skeletal muscle mass among Chinese population: a cross-sectional study
Authors:
Open Access
- 22 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1)
Abstract
Sarcopenia, characterized by progressive muscle loss, burdens aging populations. While bile acids (BAs) in skeletal muscle mass (SMM) are poorly understood, the role of amino acids (AAs) remains debated. This study investigated the associations between serum BAs, AAs, and low SMM in Chinese adults. Among 2170 initially enrolled participants, 702 were finally analyzed. Participants were classified into low and normal SMM groups. Serum BAs and AAs were quantified by targeted LC-MS/MS. Nonlinear relationships were assessed using restricted cubic spline analysis. Mediation analysis was used to assess the mediating effects of metabolic factors. The prevalence of low SMM was 14.5% (females: 21.1% vs. males: 10.2%). Multivariable logistic regression identified that increased glycocholic acid (GCA, OR = 0.561, p = 0.030), glycolithocholic acid (GLCA, OR = 0.255, p < 0.001) and deoxycholic acid (DCA, OR = 0.444, p = 0.003) were independently associated with lower risk of low SMM in the fully adjusted model. Valine (OR = 0.646, p = 0.010) and leucine (OR = 0.680, p = 0.024) showed consistent protective effects against low SMM at physiological concentrations. Mediation analysis showed BMI mediated protective effects of GCA, valine and leucine (all p < 0.01), while creatinine/cystatin C ratio mediated leucine’s effect (p = 0.030). Notably, GLCA exhibited direct protection independent of metabolic mediators (both p < 0.01). This study identified specific BAs and AAs significantly correlated with preserved SMM, suggesting that modulating BA metabolism (particularly elevating GLCA) and maintaining optimal BCAA levels may be effective strategies for low SMM. GLCA’s direct protective effect supports exploring dietary or microbiota-targeted interventions. Individual metabolic profiles, such as BMI, should be incorporated into personalized sarcopenia management.Keywords
Funding Information
- National Natural Science Foundation of China (82300622)
- National Natural Science Foundation of China (81870554)
- Shanghai Sailing Program (23YF1423100)
- Shanghai Municipal Health Commission Project (202240042)
This publication has 35 references indexed in Scilit:
- Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Glycocholic acid supplementation improved growth performance and alleviated tissue damage in the liver and intestine in Pelteobagrus fulvidraco fed a high-pectin dietFish Physiology and Biochemistry, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptorJournal of Cellular Physiology, 2020
- Age- and sex-related differences in muscle strength and physical performance in older ChineseAging Clinical and Experimental Research, 2019
- Low Levels of Branched Chain Amino Acids, Eicosapentaenoic Acid and Micronutrients are Associated with Low Muscle Mass, Strength and Function in Community-Dwelling Older AdultsThe Journal of nutrition, health and aging, 2018
- Pitfalls in the measurement of muscle mass: a need for a reference standardJournal of Cachexia, Sarcopenia and Muscle, 2018
- l-Lysine suppresses myofibrillar protein degradation and autophagy in skeletal muscles of senescence-accelerated mouse prone 8Biogerontology, 2016
- Exercise and nutritional interventions for improving aging muscle healthEndocrine, 2012
- Bioelectrical impedance analysis?part I: review of principles and methodsClinical Nutrition, 2004